Healthcare sector & Coronavirus - Podcast - April 2020

Implications for us and for Companies

No one is better placed than Dr Andy Smith to share his thoughts after a distinguished career in Pharma (SmithKline and ICON), lecturing, Fund Management, and now analysis at Equity Development.

In this 15mins podcast he manages to pack in: the medical evidence for lockdown, the likely period to get safe vaccines and drugs, the impact on specific companies, and the long term boost to the sector’s importance.